BioCentury
ARTICLE | Company News

Almirall, GW Pharma sales and marketing update

July 22, 2013 7:00 AM UTC

The partners said Almirall launched Sativex in Italy to treat moderate to severe spasticity in multiple sclerosis patients with inadequate response to other anti-spasticity medications. The partners said the sublingual cannabis extract spray containing tetrahydrocannabinol (THC) and cannabidiol (CBD) has an ex-factory price of €440 ($574.68) for a box of 3 vials, with each vial containing 90 puffs. The recommended dose is 8 puffs daily. The drug is reimbursed as a Class H (hospital-dispensed) medicine at 100% - the same pricing and reimbursement details as Spain. ...